A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)
Clinical trial NCT02772575 · WITHDRAWN
Trial details
- NCT number
- NCT02772575
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-04-01
- Primary completion
- 2017-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.